Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6236038B2 - - Google Patents
[go: Go Back, main page]

JPS6236038B2 - - Google Patents

Info

Publication number
JPS6236038B2
JPS6236038B2 JP56067136A JP6713681A JPS6236038B2 JP S6236038 B2 JPS6236038 B2 JP S6236038B2 JP 56067136 A JP56067136 A JP 56067136A JP 6713681 A JP6713681 A JP 6713681A JP S6236038 B2 JPS6236038 B2 JP S6236038B2
Authority
JP
Japan
Prior art keywords
group
compound
formula
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56067136A
Other languages
Japanese (ja)
Other versions
JPS57183794A (en
Inventor
Shigeru Torii
Hideo Tanaka
Junzo Nogami
Takashi Shiroi
Michio Sasaoka
Norio Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Priority to JP56067136A priority Critical patent/JPS57183794A/en
Priority to US06/370,034 priority patent/US4482491A/en
Priority to GB08212330A priority patent/GB2101986B/en
Priority to FR8207398A priority patent/FR2504927B1/en
Priority to DE3249933A priority patent/DE3249933C2/en
Priority to DE3249934A priority patent/DE3249934C2/de
Priority to DE3216256A priority patent/DE3216256A1/en
Publication of JPS57183794A publication Critical patent/JPS57183794A/en
Priority to FR8220933A priority patent/FR2522662B1/en
Priority to US06/625,621 priority patent/US4603014A/en
Priority to GB08418485A priority patent/GB2144418B/en
Priority to GB08500025A priority patent/GB2152051B/en
Publication of JPS6236038B2 publication Critical patent/JPS6236038B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

本発明は新芏なチアゟリノアれチゞノン誘導䜓
及びその補造法に関する。 本発明のチアゟリノアれチゞノン誘導䜓は文献
未茉の新芏化合物であり、䞋蚘䞀般匏〔〕で衚
わされる。 〔匏䞭R1はアリヌル基又はアリヌルオキシ基
を瀺す。R2はプニル環䞊にニトロ基を有する
こずのあるアリヌル䜎玚アルキル基、プニル環
䞊にニトロ基を有するこずのあるアリヌルオキシ
䜎玚アルキル基又はハロゲン原子を眮換基ずしお
有するこずのある䜎玚アルキル基を瀺す。X1及
びX2は氎玠原子又はハロゲン原子を瀺す。〕 䞊蚘䞀般匏〔〕で衚わされるチアゟリノアれ
チゞノン誘導䜓はペニシリン系、セフアロスポリ
ン系抗生物質を合成するための䞭間䜓ずしお有甚
な化合物である。䟋えば䞋蚘反応匏に埓い本発明
の化合物から抗菌剀ずしお有甚なセフアロスポリ
ン系化合物〔〕又は〔〕に誘導し埗る。 〔匏䞭R1R2X1及びX2は前蚘に同じ。〕 䞊蚘䞀般匏〔〕で衚わされるチアゟリノアれ
チゞノン誘導䜓は皮々の方法により補造される
が、その奜たしい䞀䟋を挙げれば䟋えば䞀般匏 〔匏䞭R1R2X1及びX2は前蚘に同じ。〕で衚
わされる塩玠化チアゟリノアれチゞノン誘導䜓に
塩基性化合物を䜜甚させるこずにより補造され
る。 本発明においお、R1で瀺されるアリヌル基ず
しおは䟋えばプニル基、トリル基、キシリル
基、ナフチル基、−クロルプニル基、−メ
トキシプニル基、−ニトロプニル基、−
ヒドロキシプニル基等を挙げるこずができ、た
たアリヌルオキシ基ずしおは䟋えばプノキシ
基、トリルオキシ基、キシリルオキシ基、ナフチ
ルオキシ基、−クロルプニルオキシ基、−
メトキシプニルオキシ基、−ニトロプニル
オキシ基、−ヒドロキシプニルオキシ基等を
挙げるこずができる。R2で瀺されるプニル環
䞊にニトロ基を有するこずのあるアリヌル䜎玚ア
ルキル基ずしおは䟋えばベンゞル基、−ニトロ
ベンゞル基、ゞプニルメチル基、−プニル
゚チル基、−−ニトロプニル゚チル
基、−プニルプロピル基、−−ニトロ
プニルプロピル基等を挙げるこずができ、フ
゚ニル環䞊にニトロ基を有するこずのあるアリヌ
ルオキシ䜎玚アルキル基ずしおは䟋えばプノキ
シメチル基、−ニトロプノキシメチル基、
−プノキシ゚チル基、−−ニトロプノ
キシ゚チル基、−プノキシプロピル基、
−−ニトロプノキシプロピル基等を挙げ
るこずができ、たたハロゲン原子を眮換基ずしお
有するこずのある䜎玚アルキル基ずしおは䟋えば
メチル基、゚チル基、−プロピル基、む゜プロ
ピル基、−ブチル基、tert−ブチル基、−ク
ロロ゚チル基、−トリクロロ゚チル基
等を挙げるこずができる。たたX1及びX2で瀺さ
れるハロゲン原子ずしおは䟋えば塩玠原子、臭玠
原子、北玠原子等を挙げるこずができる。 本発明においお出発原料ずしお甚いられる䞀般
匏〔〕で衚わされる塩玠化チアゟリノアれチゞ
ノン誘導䜓は新芏化合物であり、䟋えば䞋蚘反応
匏に瀺す方法により補造される。 〔匏䞭R1R2X1及びX2は前蚘に同じ。〕 䞀般匏〔〕で衚わされる化合物の電解ハロゲ
ン化は、䟋えば氎ず酢酞メチル、酢酞゚チル、ギ
酞メチル、プロピオン酞゚チル、クロロホルム、
四塩化炭玠等の有機溶媒ずの混合溶媒䞭、公知の
ハロゲン酞及び又はハロゲン化物の存圚䞋に䞀
般匏〔〕で衚わされる化合物を電解凊理すれば
よい。電解凊理の条件ずしおは、通垞玄〜
500mAcm2の範囲の電流密床で玄〜50Fmol
の電気量を通電し、玄20〜100℃の範囲の枩床で
電解を行なえばよい。 䞀般匏〔〕で衚わされる化合物ず塩玠ずの反
応は、光照射䞋適圓な有機溶媒䞭にお行なわれ
る。䜿甚される有機溶媒ずしおは塩玠に察しお䞍
掻性な溶媒をいずれも䜿甚でき、䟋えばゞクロル
メタン、ゞブロム゚タン、ゞクロル゚タン、クロ
ロホルム、四塩化炭玠等のハロゲン化炭化氎玠
類、酢酞メチル、酢酞゚チル、ギ酞メチル、酢酞
ブチル、プロピオン酞゚チル等の゚ステル類、ゞ
゚チル゚ヌテル、ゞブチル゚ヌテル、テトラヒド
ロフラン、ゞオキサン等の゚ヌテル類、アセトニ
トリル、ブチロニトリル等のニトリル類、ペンタ
ン、ヘキサン、シクロヘキサン等の炭化氎玠類、
ベンビン、トル゚ン、キシレン、クロルベンれン
等の芳銙族炭化氎玠、二硫化炭玠又はこれらの混
合溶媒等を挙げるこずができる。塩玠ずしおは通
垞分子状塩玠が甚いられる。䞀般匏〔〕で衚わ
される化合物ず塩玠ずの䜿甚割合ずしおは特に限
定がなく、広い範囲内にお適宜遞択するこずがで
きるが、通垞前者に察しお埌者を0.5〜10倍モル
量、奜たしくは〜倍モル量甚いるのがよい。
該反応は通垞−20〜100℃皋床にお行なわれる。 䞀般匏〔〕で衚わされる化合物に塩基性化合
物を䜜甚させるず脱塩酞反応が起こり䞀般匏
〔〕で衚わされる本発明の化合物が生成する。
塩基性化合物ずしおは埓来公知のものを広く䜿甚
できるが、有機アミン類を甚いるのが奜たしく、
具䜓的にはゞメチルアミン、ゞ゚チルアミン、ト
リ゚チルアミン、゚チルゞむ゜プロピルアミン、
ピペリゞン、ルチゞン、ピリゞン、−ゞア
ザビシクロ〔〕りンデセン−
−ゞアザビククロ〔〕ノネン−等
を䟋瀺できる。塩基性化合物の䜿甚量ずしおは特
に限定がなく広い範囲内で適宜遞択するこずがで
きるが、通垞䞀般匏〔〕で衚わされる化合物に
察しお0.5〜10倍モル量、奜たしくは〜倍モ
ル量甚いられる。この脱塩酞反応は有機溶媒䞭で
行な぀おもよいし、或いは䜿甚する塩基性化合物
を溶媒ずしお䜿甚するこずもできる。有機溶媒ず
しおは原料化合物、目的化合物及び塩基性化合物
に察しお䞍掻性な溶媒を広く䜿甚でき、䟋えば塩
化メチレン、クロロホルム、四塩化炭玠、ゞクロ
ル゚タン、ゞブロム゚タン等のハロゲン化炭化氎
玠類、ゞ゚チル゚ヌテル、ゞブチル゚ヌテル、テ
トラヒドロフラン、ゞオキサン等の゚ヌテル類、
ペンタン、ヘキサン、ヘプタン、オクタン等の炭
化氎玠類、ベンれン、クロルベンれン、トル゚
ン、キシレン等の芳銙族炭化氎玠類等を挙げるこ
ずができる。該反応は宀枩䞋、加枩䞋及び冷华䞋
のいずれでも行なわれるが、通垞−20〜80℃の範
囲内で行なうのがよい。 斯くしお埗られる本発明の化合物は通垞行なわ
れおいる分離手段、䟋えば溶媒抜出、カラムクロ
マトグラフむヌ等の手段により反応混合物から容
易に単離粟補される。 本発明の化合物に構造䞊類䌌する化合物ずしお
は匏 で瀺される化合物がJ.A.C.S.9750081975
やPure Appl.Chem.434231975に蚘茉さ
れおおり、該化合物は䞋蚘反応匏に埓い合成され
る。 匏〔〕の化合物から匏〔〕の化合物を埗る
反応は−ブロモサクシンむミド及びラゞカル開
始剀を甚いお加熱、玫倖線照射䞋に行なわれる。
このブロム化は䜍にメトキシ基を有しおいる匏
〔〕の化合物であるからこそ可胜であ぀たので
あり、メトキシ基の代りに氎玠原子で眮換された
化合物の堎合にはブロム化は進行しない。 これに察しお本発明の方法によれば、特殊な詊
薬を䜿甚するこずなく、枩和な条件䞋に簡䟿に䞔
぀高収率で目的化合物を収埗し埗る。しかも目的
物の分離、粟補も容易であり、副生物等の廃棄物
の問題がなく、工業的にも極めお有利な方法であ
る。 以䞋に参考䟋及び実斜䟋を挙げる。 参考䟋  塩化ナトリりム1gを氎mlに溶解し、これに
濃硫酞0.07ml、塩化メチレンml及び化合物
〔〕R1プニル、R2メチル50mgを加え
電解液を調補する。cm2の癜金板電極を装入し
30mA定電流、1.6〜1.8V、25℃で玄時間電解を
行う。電解終了埌塩化メチレン30mlで抜出を
行う。抜出液は亜硫酞ナトリりム氎、重゜り氎、
食塩氎で掗浄埌無氎硫酞ナトリりムで也燥し、溶
媒を陀去しお淡黄色の液䜓74mgを埗た。このもの
をシリカゲルカラムを甚い、ベンれン酢酞゚チ
ルの混合溶媒で展開するず目的化合物
〔〕R1プニル、R2メチル、X1X2
Clが62.5mg収率96埗られた。 IR 17801745cm-1 NMRCDCl3 3.753HCOOH3 3.812H−CH2Cl 5.142HCH2 5.411H
The present invention relates to a novel thiazolinoazetidinone derivative and a method for producing the same. The thiazolinoazetidinone derivative of the present invention is a novel compound that has not been described in any literature, and is represented by the following general formula []. [In the formula, R 1 represents an aryl group or an aryloxy group. R 2 is an aryl lower alkyl group that may have a nitro group on the phenyl ring, an aryloxy lower alkyl group that may have a nitro group on the phenyl ring, or a lower alkyl group that may have a halogen atom as a substituent. show. X 1 and X 2 represent a hydrogen atom or a halogen atom. ] The thiazolinoazetidinone derivative represented by the above general formula [ ] is a compound useful as an intermediate for synthesizing penicillin and cephalosporin antibiotics. For example, a cephalosporin compound [a] or [b] useful as an antibacterial agent can be derived from the compound of the present invention according to the following reaction formula. [In the formula, R 1 , R 2 , X 1 and X 2 are the same as above. ] The thiazolinoazetidinone derivative represented by the above general formula [] can be produced by various methods. [In the formula, R 1 , R 2 , X 1 and X 2 are the same as above. ] is produced by reacting a basic compound with a chlorinated thiazolinoazetidinone derivative. In the present invention, examples of the aryl group represented by R 1 include phenyl group, tolyl group, xylyl group, naphthyl group, p-chlorophenyl group, p-methoxyphenyl group, p-nitrophenyl group, p-
Examples of aryloxy groups include phenoxy, tolyloxy, xylyloxy, naphthyloxy, p-chlorophenyloxy, and p-chlorophenyloxy groups.
Examples include methoxyphenyloxy group, p-nitrophenyloxy group, and p-hydroxyphenyloxy group. Examples of the aryl lower alkyl group that may have a nitro group on the phenyl ring represented by R2 include benzyl group, p-nitrobenzyl group, diphenylmethyl group, 2-phenylethyl group, 2-(p-nitrophenyl)ethyl group, Examples of aryloxy lower alkyl groups that may have a nitro group on the phenyl ring include 3-phenylpropyl group and 3-(p-nitrophenyl)propyl group, such as phenoxymethyl group and p-nitrophenyl group. dimethyl group, 2
-Phenoxyethyl group, 2-(p-nitrophenoxy)ethyl group, 3-phenoxypropyl group, 3
-(p-nitrophenoxy)propyl group, and examples of lower alkyl groups that may have a halogen atom as a substituent include methyl group, ethyl group, n-propyl group, isopropyl group, and n-butyl group. , tert-butyl group, 2-chloroethyl group, 2,2,2-trichloroethyl group, and the like. Examples of the halogen atom represented by X 1 and X 2 include a chlorine atom, a bromine atom, and a fluorine atom. The chlorinated thiazolinoazetidinone derivative represented by the general formula [] used as a starting material in the present invention is a new compound, and is produced, for example, by the method shown in the reaction formula below. [In the formula, R 1 , R 2 , X 1 and X 2 are the same as above. ] Electrolytic halogenation of the compound represented by the general formula [ ] can be carried out using, for example, water and methyl acetate, ethyl acetate, methyl formate, ethyl propionate, chloroform,
The compound represented by the general formula [] may be electrolytically treated in the presence of a known halogen acid and/or halide in a mixed solvent with an organic solvent such as carbon tetrachloride. The conditions for electrolytic treatment are usually about 5~
Approximately 2-50F/mol at current density in the range of 500mA/ cm2
It is sufficient to conduct electrolysis at a temperature in the range of about 20 to 100°C by applying an amount of electricity. The reaction between the compound represented by the general formula [] and chlorine is carried out in a suitable organic solvent under irradiation with light. As the organic solvent used, any solvent inert to chlorine can be used, such as dichloromethane, dibromoethane, dichloroethane, chloroform, halogenated hydrocarbons such as carbon tetrachloride, methyl acetate, ethyl acetate, methyl formate, Esters such as butyl acetate and ethyl propionate; ethers such as diethyl ether, dibutyl ether, tetrahydrofuran, and dioxane; nitriles such as acetonitrile and butyronitrile; hydrocarbons such as pentane, hexane, and cyclohexane;
Examples include aromatic hydrocarbons such as benbin, toluene, xylene, and chlorobenzene, carbon disulfide, and mixed solvents thereof. Molecular chlorine is usually used as chlorine. The ratio of the compound represented by the general formula [] and chlorine to be used is not particularly limited and can be appropriately selected within a wide range, but the latter is usually 0.5 to 10 times the molar amount of the former, preferably It is preferable to use 1 to 5 times the molar amount.
The reaction is usually carried out at about -20 to 100°C. When a basic compound is allowed to act on the compound represented by the general formula [], a dehydrochlorination reaction occurs to produce the compound of the present invention represented by the general formula [].
Although a wide range of conventionally known basic compounds can be used, it is preferable to use organic amines.
Specifically, dimethylamine, diethylamine, triethylamine, ethyldiisopropylamine,
piperidine, lutidine, pyridine, 1,5-diazabicyclo[5,4,0]undecene-5,1,
Examples include 5-diazabicucro[4,3,0]nonene-5. The amount of the basic compound to be used is not particularly limited and can be appropriately selected within a wide range, but it is usually 0.5 to 10 times the molar amount, preferably 1 to 5 times the molar amount of the compound represented by the general formula []. amount used. This dehydrochlorination reaction may be carried out in an organic solvent, or the basic compound used may be used as a solvent. As the organic solvent, a wide range of solvents can be used that are inert to the starting compound, target compound, and basic compound, such as halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, and dibromoethane, diethyl ether, and Ethers such as butyl ether, tetrahydrofuran, dioxane,
Examples include hydrocarbons such as pentane, hexane, heptane, and octane, and aromatic hydrocarbons such as benzene, chlorobenzene, toluene, and xylene. The reaction may be carried out at room temperature, under heating or under cooling, but is preferably carried out usually within the range of -20 to 80°C. The compound of the present invention thus obtained can be easily isolated and purified from the reaction mixture by conventional separation means such as solvent extraction and column chromatography. Compounds structurally similar to the compounds of the present invention include the formula The compound shown in JACS, 97, 5008 (1975)
and Pure Appl.Chem., 43 , 423 (1975), and the compound is synthesized according to the following reaction formula. The reaction for obtaining the compound of formula [] from the compound of formula [] is carried out using N-bromosuccinimide and a radical initiator under heating and ultraviolet irradiation.
This bromination was possible because the compound of the formula [] has a methoxy group at the 3-position; in the case of a compound in which a hydrogen atom is substituted for the methoxy group, bromination can proceed. do not. In contrast, according to the method of the present invention, the target compound can be obtained simply and in high yield under mild conditions without using any special reagents. Moreover, separation and purification of the target product are easy, there is no problem of waste such as by-products, and this method is extremely advantageous from an industrial perspective. Reference examples and examples are listed below. Reference Example 1 1 g of sodium chloride is dissolved in 3 ml of water, and 0.07 ml of concentrated sulfuric acid, 5 ml of methylene chloride, and 50 mg of the compound [] (R 1 = phenyl, R 2 = methyl) are added to prepare an electrolytic solution. Insert a 3 cm 2 platinum plate electrode.
Electrolyze at 30 mA constant current, 1.6 to 1.8 V, and 25°C for about 2 hours. After the electrolysis is complete, extract with methylene chloride (30ml). Extract liquid is sodium sulfite water, hydrogenated sodium water,
After washing with brine and drying over anhydrous sodium sulfate, the solvent was removed to obtain 74 mg of a pale yellow liquid. When this product was developed using a silica gel column with a mixed solvent of benzene:ethyl acetate (5:1), the target compound [] (R 1 = phenyl, R 2 = methyl, X 1 = X 2 =
Cl) was obtained in an amount of 62.5 mg (yield 96%). (IR) 1780, 1745cm -1 NMR (CDCl 3 ) 3.75 (3H, s, COOH 3 ) 3.81 (2H, s, -CH 2 Cl) 5.14 (2H, s, C=CH 2 ) 5.41 (1H, s,

【匏】 6.052H【formula】 6.05(2H,s,

【匏】 7.3〜7.95Hプニル 参考䟋  化合物〔〕R1プニル、R2メチル、X1
X2Cl50mgを塩化メチレン0.5mlに溶解し、
塩玠の飜和した塩化メチレン溶液1.5mlを加え
る。盎ちに750Wタングステンランプを甚いお光
照射しながら20〜27℃の範囲で時間反応を行
う。反応終了埌反応液を氷氎に泚ぎ、塩化メチレ
ン局を分離する。チオ硫酞ナトリりム氎溶液、飜
和食塩氎で掗浄した埌、無氎硫酞ナトリりムで也
燥する。枛圧䞋溶媒を陀去し、残枣をベンれン−
酢酞゚チルを溶媒ずしおシリカゲルカ
ラムで分離、粟補するず50.05mgの化合物〔〕
R1プニル、R2メチル、X1X2Clを埗
る。収率86 IRcm-11770、1760 NMRCDCl3Ύ 3.803H、3.98bs2H 4.122H、5.121H 6.101H、6.281H 7.2〜7.53H 7.5〜7.82H 実斜䟋  化合物〔〕R1プニル、R2メチル、X1
X255mgを塩化メチル0.6mlに溶解し、こ
れにトリ゚チルアミン88Όを加え、宀枩で撹拌
する。時間反応を行぀た埌゚ヌテルmlを加
え、次に氎を加えお掗浄する。続いお10塩酞、
飜和食塩氎で掗浄する。゚ヌテル局を無氎硫酞ナ
トリりムで也燥し、枛圧䞋溶媒を陀去する。残枣
をシリカゲルカラムで粟補するず、無色油状物ず
しお目的物〔〕R1プニル、R2メチル、
X1X2を埗る。収率98 IRcm-1 17701720 NMRCDCl3Ύ 3.763H、3.902H 4.07bs2H、4.63bs2H 5.831H、6.30bd1H 7.255H 実斜䟋 〜 実斜䟋ず同様の操䜜、凊理を行う。結果を第
〜衚に瀺す。尚衚䞭Phはプニル基を意味
する。
[Formula] 7.3-7.9 (5H, m, phenyl) Reference example 2 Compound [] (R 1 = phenyl, R 2 = methyl, X 1
=X 2 =Cl) 50mg was dissolved in methylene chloride 0.5ml,
Add 1.5 ml of chlorine saturated methylene chloride solution. Immediately, reaction is carried out for 1 hour at 20 to 27°C while irradiating with light using a 750W tungsten lamp. After the reaction is completed, the reaction solution is poured into ice water and the methylene chloride layer is separated. After washing with an aqueous sodium thiosulfate solution and saturated saline, drying with anhydrous sodium sulfate. The solvent was removed under reduced pressure and the residue was dissolved in benzene.
Separation and purification with a silica gel column using ethyl acetate (9:1) as a solvent yielded 50.05 mg of the compound []
R 1 = phenyl, R 2 = methyl, X 1 = X 2 = Cl). Yield 86% IR (cm -1 ) 1770, 1760 NMR (CDCl 3 ÎŽ) 3.80 (s, 3H), 3.98 (bs, 2H) 4.12 (s, 2H), 5.12 (s, 1H) 6.10 (d, 1H) ), 6.28 (d, 1H) 7.2-7.5 (m, 3H) 7.5-7.8 (m, 2H) Example 1 Compound [] (R 1 = phenyl, R 2 = methyl, X 1
=X 2 =H) 55mg is dissolved in 0.6ml of methyl chloride, 88Ό of triethylamine is added thereto, and the mixture is stirred at room temperature. After 2 hours of reaction, 5 ml of ether was added and then water was added for washing. followed by 10% hydrochloric acid,
Wash with saturated saline. The ether layer was dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure. When the residue was purified with a silica gel column, the desired product [] (R 1 = phenyl, R 2 = methyl,
X 1 =X 2 =H) is obtained. Yield 98% IR (cm -1 ) 1770, 1720 NMR (CDCl 3 ÎŽ) 3.76 (s, 3H), 3.90 (s, 2H) 4.07 (bs, 2H), 4.63 (bs, 2H) 5.83 (d, 1H ), 6.30 (bd, 1H) 7.25 (s, 5H) Examples 2 to 7 The same operations and processes as in Example 1 are performed. The results are shown in Tables 1 and 2. In addition, Ph in the table means a phenyl group.

【衚】【table】

【衚】【table】

【衚】 実斜䟋 〜19 実斜䟋ず同様の操䜜、凊理を行う。結果を第
衚に瀺す。尚衚䞭Phはプニル基を意味す
る。
[Table] Examples 8 to 19 The same operations and treatments as in Example 1 were performed. The results are shown in Table 3. In addition, Ph in the table means a phenyl group.

【衚】【table】

【衚】【table】

Claims (1)

【特蚱請求の範囲】  䞀般匏 〔匏䞭R1はアリヌル基又はアリヌルオキシ基
を瀺す。R2はプニル環䞊にニトロ基を有する
こずのあるアリヌル䜎玚アルキル基、プニル環
䞊にニトロ基を有するこずのあるアリヌルオキシ
䜎玚アルキル基又はハロゲン原子を眮換基ずしお
有するこずのある䜎玚アルキル基を瀺す。X1及
びX2は氎玠原子又はハロゲン原子を瀺す。〕で衚
わされるチアゟリノアれチゞノン誘導䜓。  䞀般匏 〔匏䞭R1はアリヌル基又はアリヌルオキシ基
を瀺す。R2はプニル環䞊にニトロ基を有する
こずのあるアリヌル䜎玚アルキル基、プニル環
䞊にニトロ基を有するこずのあるアリヌルオキシ
䜎玚アルキル基又はハロゲン原子を眮換基ずしお
有するこずのある䜎玚アルキル基を瀺す。X1及
びX2は氎玠原子又はハロゲン原子を瀺す。〕で衚
わされるチアゟリノアれチゞノン誘導䜓に塩基性
化合物を䜜甚させお䞀般匏 〔匏䞭R1R2X1及びX2は前蚘に同じ。〕で衚
わされるチアゟリノアれチゞノン誘導䜓を埗るこ
ずを特城ずするチアゟリノアれチゞノン誘導䜓の
補造法。
[Claims] 1. General formula [In the formula, R 1 represents an aryl group or an aryloxy group. R 2 is an aryl lower alkyl group that may have a nitro group on the phenyl ring, an aryloxy lower alkyl group that may have a nitro group on the phenyl ring, or a lower alkyl group that may have a halogen atom as a substituent. show. X 1 and X 2 represent a hydrogen atom or a halogen atom. ] A thiazolinoazetidinone derivative represented by 2 General formula [In the formula, R 1 represents an aryl group or an aryloxy group. R 2 is an aryl lower alkyl group that may have a nitro group on the phenyl ring, an aryloxy lower alkyl group that may have a nitro group on the phenyl ring, or a lower alkyl group that may have a halogen atom as a substituent. show. X 1 and X 2 represent a hydrogen atom or a halogen atom. ] By reacting a basic compound with a thiazolinoazetidinone derivative represented by [In the formula, R 1 , R 2 , X 1 and X 2 are the same as above. A method for producing a thiazolinoazetidinone derivative, which comprises obtaining a thiazolinoazetidinone derivative represented by the formula:
JP56067136A 1981-05-01 1981-05-01 Thiazolinoazetidinone derivative and its preparation Granted JPS57183794A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP56067136A JPS57183794A (en) 1981-05-01 1981-05-01 Thiazolinoazetidinone derivative and its preparation
US06/370,034 US4482491A (en) 1981-05-01 1982-04-20 Thiazolinoazetidinone derivatives and process for the preparation of the same
GB08212330A GB2101986B (en) 1981-05-01 1982-04-28 Thiazolinoazetidinone derivatives
FR8207398A FR2504927B1 (en) 1981-05-01 1982-04-29 THIAZOLINOAZETIDINONE DERIVATIVES, METHODS FOR THEIR PREPARATIONS AND THEIR USE IN THE PREPARATION OF CEPHALOSPORINS
DE3249934A DE3249934C2 (en) 1981-05-01 1982-04-30
DE3249933A DE3249933C2 (en) 1981-05-01 1982-04-30 Process for the preparation of 2- [4- (aryl or heteroaryldithio) -2-azetidinon-1-yl] -3-halomethyl-3-butenoic acid derivatives
DE3216256A DE3216256A1 (en) 1981-05-01 1982-04-30 THIAZOLINOAZETIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
FR8220933A FR2522662B1 (en) 1981-05-01 1982-12-14 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS
US06/625,621 US4603014A (en) 1981-05-01 1984-06-28 Thiazolinoazetidinone derivatives and process for the preparation of the same
GB08418485A GB2144418B (en) 1981-05-01 1984-07-19 Thiazolinoazetidinone derivatives and process for the preparation of the same
GB08500025A GB2152051B (en) 1981-05-01 1985-01-02 Process for the preparation of azetidinone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56067136A JPS57183794A (en) 1981-05-01 1981-05-01 Thiazolinoazetidinone derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS57183794A JPS57183794A (en) 1982-11-12
JPS6236038B2 true JPS6236038B2 (en) 1987-08-05

Family

ID=13336177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56067136A Granted JPS57183794A (en) 1981-05-01 1981-05-01 Thiazolinoazetidinone derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS57183794A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57185295A (en) * 1981-05-08 1982-11-15 Otsuka Chem Co Ltd Thiazolinoazetidinone derivative and its preparation

Also Published As

Publication number Publication date
JPS57183794A (en) 1982-11-12

Similar Documents

Publication Publication Date Title
US4784734A (en) Azetidinone derivatives and process for the preparation of the same
US4603014A (en) Thiazolinoazetidinone derivatives and process for the preparation of the same
CA1058615A (en) Process for benz(f)-2,5-oxazocines
JPS6236038B2 (en)
JPH0141152B2 (en)
Gunda et al. 2-Amino-1-phenyl-propan-1, 3-diol as chiral auxiliary. Application in the synthesis of cis 3-Phthalimido-4-styryl-2-azetidinones
JPS632435B2 (en)
JPS6236037B2 (en)
JPH0459310B2 (en)
SU833162A3 (en) Method of preparing 1-oxadethiacephalosporins
JPH0247473B2 (en)
US4464237A (en) Process for preparing β-lactam derivatives
EP0122002B1 (en) Process for preparing azetidinone derivatives
JP2602669B2 (en) Method for producing 2β-halogeno-substituted methylpenicillin derivative
JPH0141153B2 (en)
JP3201998B2 (en) Method for producing (S) -benzoxazine derivative and method for racemizing (R) -benzoxazine derivative
JPS6024187B2 (en) Method for producing β-lactam derivatives
EP0120094B1 (en) Azetidinone compounds
EP0831156A1 (en) Process for the preparation of 3-alkoxymethylcephems
JPH0827132A (en) Production of 5-oxazolones
JPS6043340B2 (en) Chlorinated azetidinone derivatives and their production method
JPS6236036B2 (en)
JPH0244474B2 (en) KARUBASE FUEMUKAGOBUTSU
JPH09227542A (en) Production of tetrahydrofuran derivative
JPH05221947A (en) Production of cyclopropane derivative